Physician profile

Rami Zein

Cardiovascular Disease · Detroit, MI

NPI 1134531098

$15,980.01

in general payments reported to CMS, 2019-2025

38 companies · $6,458 in 2025

The $6,458 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,206.33
Travel and Lodging$4,433.26
Education$18.85

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $4,744.41 2024-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal
Medtronic, INC. $2,393.73 2022-2025 Corevalve Evolut R, Micra, Symplicity G3
Abbott Laboratories $2,232.34 2019-2025 Optis, Pressurewire, Esprit
Inari Medical, INC. $981.93 2022-2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Amgen INC. $893.40 2019-2025 Repatha, Repatha
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $625.00 2019-2025 Lifevest
Abiomed $537.25 2024-2025 Impella
Boston Scientific Corporation $508.88 2021-2025 Watchman Flx, General - Thrombectomy, Eluvia
Cardiovascular Systems INC. $338.72 2020-2021
Stryker Corporation $292.68 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever
Shockwave Medical, INC $285.11 2022-2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Boehringer Ingelheim Pharmaceuticals, INC. $215.38 2023-2025 Jardiance
Kestra Medical Technology Services, INC. $210.17 2024-2025 Assure Wcd
Chiesi USA, INC. $192.96 2023-2025 Kengreal, Cleviprex
Astrazeneca Pharmaceuticals LP $166.17 2019
Show all 38 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $144.97 2023-2025 Camzyos, Eliquis
Janssen Pharmaceuticals, INC $135.00 2019-2024 Xarelto
Recor Medical INC $110.20 2024 Paradise Renal Denervation System
Cardinal Health 200 LLC $102.96 2019-2021
Surmodics, INC. $97.11 2025 Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System
Heartflow, INC. $96.00 2025
Novartis Pharmaceuticals Corporation $87.60 2019-2025
Getinge USA Sales, LLC $79.10 2020-2024 Icast, Flixene
Angiodynamics, INC. $59.43 2020-2024 Venacure 1470 Pro, Auryon Laser System 100-120 Vac
Teleflex LLC $53.51 2023-2025 Guideliner, Turnpike
Cathworks, INC. $51.98 2023-2024 Ffrangio
Pfizer INC. $51.87 2023-2024
Tactile Systems Technology INC $42.81 2025 Flexitouch Plus, Nimbl
Novo Nordisk INC $38.88 2022-2025 Wegovy
Cardiva Medical, INC. $38.63 2023 Cardiva Vascade 6/7f Vcs
Kiniksa Pharmaceuticals International, Plc $31.15 2024 Arcalyst
Actelion Pharmaceuticals US, INC. $29.96 2025 Opsumit, Uptravi
Penumbra, INC. $24.76 2025 Penumbra System
Bard Peripheral Vascular, INC. $23.19 2023 Venclose Maven Catheter
Cordis US Corp. $17.36 2024 Mynxgrip
Baxter Healthcare $15.50 2023 Hillrom - Carnation Ambulatory Monitor
Bsn Medical INC $15.24 2022
Regeneron Healthcare Solutions, INC. $14.67 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rami Zein

$15,980.01

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $6,458 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/424259/rami-zein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.